Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...
The vaccine candidate is the furthest any shot has gotten since the last one was pulled in 2002. Scientists are testing other ...
Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.
The suspicion bubbling up around the unreleased vaccine, Offit says, precisely calls to mind what has happened to vaccines ...
Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to ...
Hosted on MSN
Pfizer lags as Cadrenal advances to Phase 3 trial
Pfizer shares remain under pressure amid declining COVID vaccine demand, looming patent expirations, and delays in entering the GLP-1 weight-loss market. Meanwhile, Cadrenal Therapeutics gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results